SENSUS HEALTHCARE, INC. Financials Sensus Healthcare, Inc.
Equities
SRTS
US81728J1097
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.48 USD | +2.05% |
|
+3.24% | +48.31% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 58.4 | 63.7 | 120 | 123.3 | 38.66 | 55.9 | - |
| Enterprise Value (EV) 1 | 58.4 | 63.7 | 120 | 123.3 | 38.66 | 55.9 | 55.9 |
| P/E ratio | -35.4 x | -9.19 x | 28.9 x | 5.08 x | 78.7 x | 75.8 x | 17.1 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 2.14 x | 6.65 x | 4.44 x | 2.77 x | 1.58 x | 2.13 x | 1.73 x |
| EV / Revenue | 2.14 x | 6.65 x | 4.44 x | 2.77 x | 1.58 x | 2.13 x | 1.73 x |
| EV / EBITDA | -72,849,106 x | -11,021,117 x | 23,300,975 x | 4,384,357 x | 147,005,601 x | - | - |
| EV / FCF | -23,292,340 x | - | - | - | - | - | - |
| FCF Yield | -0% | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 16,497 | 16,502 | 16,617 | 16,612 | 16,382 | 16,394 | - |
| Reference price 2 | 3.540 | 3.860 | 7.220 | 7.420 | 2.360 | 3.410 | 3.410 |
| Announcement Date | 2/13/20 | 2/25/21 | 2/10/22 | 2/9/23 | 2/8/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 27.26 | 9.577 | 27.04 | 44.53 | 24.4 | 26.3 | 32.26 |
| EBITDA | -0.8016 | -5.78 | 5.149 | 28.11 | 0.263 | - | - |
| EBIT 1 | -1.968 | -8.234 | 4.12 | 14.83 | -0.382 | 0.647 | 4.41 |
| Operating Margin | -7.22% | -85.98% | 15.24% | 33.3% | -1.57% | 2.46% | 13.67% |
| Earnings before Tax (EBT) 1 | -1.7 | -6.836 | 4.119 | 27.99 | 0.652 | 1.047 | 4.41 |
| Net income 1 | -1.7 | -6.836 | 4.119 | 24.24 | 0.485 | 0.792 | 3.396 |
| Net margin | -6.24% | -71.37% | 15.23% | 54.44% | 1.99% | 3.01% | 10.53% |
| EPS 2 | -0.1000 | -0.4200 | 0.2500 | 1.460 | 0.0300 | 0.0450 | 0.2000 |
| Free Cash Flow | -2.507 | - | - | - | - | - | - |
| FCF margin | -9.2% | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 2/13/20 | 2/25/21 | 2/10/22 | 2/9/23 | 2/8/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 5.525 | 13.02 | 10.34 | 12.08 | 9.01 | 13.1 | 3.414 | 4.527 | 3.898 | 12.57 | 4.12 | 5.692 | 4.982 | 11.5 |
| EBITDA | 0.527 | 5.55 | 16.86 | 4.684 | 2.276 | 4.294 | -2.724 | -0.976 | -1.726 | 5.689 | - | - | - | - |
| EBIT 1 | 0.195 | 5.319 | 3.93 | 4.57 | 2.161 | 4.173 | -2.939 | -1.127 | -1.895 | 5.577 | -1.269 | -0.375 | -0.829 | 3.12 |
| Operating Margin | 3.53% | 40.84% | 38.02% | 37.83% | 23.98% | 31.84% | -86.09% | -24.9% | -48.61% | 44.38% | -30.8% | -6.59% | -16.64% | 27.12% |
| Earnings before Tax (EBT) 1 | 0.195 | 5.318 | 16.71 | 4.594 | 2.279 | 4.408 | -2.696 | -0.882 | -1.576 | 5.805 | -1.169 | -0.275 | -0.729 | 3.22 |
| Net income 1 | 0.195 | 5.318 | 16.06 | 3.524 | 1.829 | 2.831 | -1.894 | -0.38 | -1.451 | 4.21 | -0.9115 | -0.2225 | -0.573 | 2.499 |
| Net margin | 3.53% | 40.83% | 155.37% | 29.17% | 20.3% | 21.6% | -55.48% | -8.39% | -37.22% | 33.5% | -22.12% | -3.91% | -11.5% | 21.72% |
| EPS 2 | 0.0100 | 0.3200 | 0.9700 | 0.2100 | 0.1100 | 0.1700 | -0.1200 | -0.0200 | -0.0900 | 0.2600 | -0.0550 | -0.0150 | -0.0350 | 0.1500 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 2/10/22 | 5/5/22 | 8/4/22 | 11/3/22 | 2/9/23 | 5/3/23 | 8/3/23 | 11/9/23 | 2/8/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | -2.51 | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - |
| Announcement Date | 2/13/20 | 2/25/21 | 2/10/22 | 2/9/23 | 2/8/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.41
USD
Average target price
7.5
USD
Spread / Average Target
+119.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +48.31% | 55.9M | |
| -11.70% | 19.08B | |
| -44.46% | 2.65B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| +26.18% | 1.21B | |
| -10.69% | 1.02B | |
| -20.89% | 905M | |
| -4.49% | 716M | |
| -17.51% | 682M |
- Stock Market
- Equities
- SRTS Stock
- Financials Sensus Healthcare, Inc.
